{"id":"W2809860024","doi":"10.1002/clc.23018","title":"Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial","year":2018,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital","funders":"Amgen","keywords":"Evolocumab; Medicine; Dyslipidemia; PCSK9; Internal medicine; Atorvastatin; Placebo; Hyperlipidemia; Statin; Diabetes mellitus; Type 2 diabetes; Gastroenterology; Familial hypercholesterolemia; Alirocumab; Endocrinology; Cholesterol; Lipoprotein; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06067276,0.005530833,0.006165888,0.001590783,0.00263381,0.002832037,0.002855595,0.007217109,0.01646431],"category_scores_gemma":[0.03755531,0.003275815,0.003602226,0.001545155,0.005144634,0.002523201,0.001592586,0.007725677,0.005734978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001637258,"about_ca_system_score_gemma":0.007514574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005745227,"about_ca_topic_score_gemma":0.001056404,"domain_scores_codex":[0.9534496,0.03516591,0.002647124,0.003301422,0.003550603,0.001885282],"domain_scores_gemma":[0.9858245,0.004964,0.002290868,0.002258464,0.001998629,0.002663519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9081942,0.01196462,0.003860292,0.007912439,0.002985328,0.0005896564,0.0003860419,0.001623207,0.004087493,0.01196784,0.01263559,0.03379348],"study_design_scores_gemma":[0.9000889,0.04928075,0.002992908,0.001421983,0.00201582,0.0002358553,0.00008775754,0.002353061,0.001097939,0.005827313,0.03446876,0.0001289747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.02460578,0.005305391,0.01418834,0.004424294,0.006054303,0.9370725,0.002499321,0.000350814,0.005499433],"genre_scores_gemma":[0.04351144,0.001399642,0.02010493,0.005692423,0.001630573,0.9246032,0.0008462319,0.00003586924,0.002175722],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.06067276,"threshold_uncertainty_score":0.3208721,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0840738462412197,"score_gpt":0.3879460096833942,"score_spread":0.3038721634421744,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}